The Investigational New Drug CDMO market is anticipated to exceed USD 7.47 billion by 2031, with a compound annual growth rate (CAGR) of 5.56% over the forecast period.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Investigational New Drug CDMO Market By Product (Small Molecule, Large Molecule), Contract Development (Small Molecule (Bioanalysis and DMPK studies, Toxicology Testing, Pathology and safety pharmacology studies, Drug…
Read More…